ARCHIVES

High Risk Youth Targeted In Concept Ok’d By Advisors

This article is from The Cancer Letter archive.

Vol. 17 No. 06 | February 8, 1991

Download PDF Visit The Full Archive

Related Articles

Lung Cancer Survivors Claim Good QOL, Despite Challenges

August 30, 2002

Revive Comprehensive Program, But Don’t Tie It to Grant Review, Center Executive Agrees

July 29, 1988

NCI Says Review Group Will Read Blueprint, Evaluate NCI Research

January 16, 1998

Elias Zerhouni Nominated for NIH Director; Richard Carmona For Surgeon General

April 5, 2002

Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal

June 18, 1982

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005